Sale!

CRB2 Gene Ventriculomegaly with Cystic Kidney Disease Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “CRB2 Gene Ventriculomegaly with Cystic Kidney Disease Genetic Test” is a specialized diagnostic assessment offered by DNA Labs UAE, aimed at detecting mutations in the CRB2 gene, which are associated with the development of ventriculomegaly and cystic kidney disease. Ventriculomegaly is characterized by the abnormal enlargement of brain ventricles, while cystic kidney disease involves the formation of fluid-filled sacs in the kidneys, potentially leading to impaired kidney function. This genetic test is crucial for individuals with a family history or clinical symptoms suggestive of these conditions, as early detection can significantly influence management and treatment strategies. The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring accurate and reliable results through advanced genetic testing technologies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CRB2 Gene Ventriculomegaly with cystic kidney disease Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CRB2 Gene Ventriculomegaly with cystic kidney disease NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CRB2 Gene Ventriculomegaly with cystic kidney disease

Test Details

The CRB2 gene is associated with a condition called ventriculomegaly with cystic kidney disease. This genetic test, known as NGS (Next-Generation Sequencing), is used to analyze the DNA sequence of the CRB2 gene and identify any mutations or variations that may be present.

Ventriculomegaly is a condition characterized by the enlargement of the brain’s ventricles, which are fluid-filled spaces. This can lead to various neurological symptoms and developmental delays. Cystic kidney disease, on the other hand, is a condition characterized by the development of fluid-filled cysts in the kidneys, which can lead to kidney dysfunction and other complications.

NGS is a high-throughput DNA sequencing technique that allows for the simultaneous analysis of multiple genes, including the CRB2 gene. This test can identify specific mutations or variations in the CRB2 gene that may be responsible for the development of ventriculomegaly with cystic kidney disease.

By identifying these genetic abnormalities, healthcare professionals can provide a more accurate diagnosis, assess the prognosis, and potentially offer targeted treatment options or genetic counseling for affected individuals and their families.

Test Name CRB2 Gene Ventriculomegaly with cystic kidney disease Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CRB2 Gene Ventriculomegaly with cystic kidney disease NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CRB2 Gene Ventriculomegaly with cystic kidney disease
Test Details

The CRB2 gene is associated with a condition called ventriculomegaly with cystic kidney disease. This genetic test, known as NGS (Next-Generation Sequencing), is used to analyze the DNA sequence of the CRB2 gene and identify any mutations or variations that may be present.

Ventriculomegaly is a condition characterized by the enlargement of the brain’s ventricles, which are fluid-filled spaces. This can lead to various neurological symptoms and developmental delays. Cystic kidney disease, on the other hand, is a condition characterized by the development of fluid-filled cysts in the kidneys, which can lead to kidney dysfunction and other complications.

NGS is a high-throughput DNA sequencing technique that allows for the simultaneous analysis of multiple genes, including the CRB2 gene. This test can identify specific mutations or variations in the CRB2 gene that may be responsible for the development of ventriculomegaly with cystic kidney disease. By identifying these genetic abnormalities, healthcare professionals can provide a more accurate diagnosis, assess the prognosis, and potentially offer targeted treatment options or genetic counseling for affected individuals and their families.